Patients with rheumatic diseases who were not vaccinated against SARS-CoV-2 experienced more severe outcomes throughout the various 'epochs' of the pandemic.
Patients with rheumatic diseases who were not vaccinated against SARS-CoV-2 experienced more severe outcomes throughout the various 'epochs' of the pandemic.
No evidence has been found of increased risks of adverse events with COVID-19 vaccination among patients with spondyloarthritis treated with most disease-modifying antirheumatic drugs.
No evidence has been found of increased risks of adverse events with COVID-19 vaccination among patients with spondyloarthritis treated with most disease-modifying antirheumatic drugs.
Investigators used 2 international registries to predict severe COVID-19 outcomes assessed among patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis.
Investigators used 2 international registries to predict severe COVID-19 outcomes assessed among patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis.
Researchers sought to determine if an association exists between outcomes of COVID-19 and the race or ethnicity of patients with systemic lupus erythematosus.
Researchers sought to determine if an association exists between outcomes of COVID-19 and the race or ethnicity of patients with systemic lupus erythematosus.
Researchers evaluated hybrid immunity and humoral immune response and safety of booster doses for COVID-19 among adults with immune-mediated inflammatory diseases.
Researchers evaluated hybrid immunity and humoral immune response and safety of booster doses for COVID-19 among adults with immune-mediated inflammatory diseases.
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
